Related references
Note: Only part of the references are listed.Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K. Accorsi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
Zhengnan Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design and Evaluation of a Novel Peptide-Drug Conjugate Covalently Targeting SARS-CoV-2 Papain-like Protease
Na Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni et al.
NATURE (2022)
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao et al.
NATURE (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Katherine G. Nabel et al.
SCIENCE (2022)
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
Panpan Zhou et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwe Li et al.
CELL REPORTS (2022)
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
Jingwen Ai et al.
EMERGING MICROBES & INFECTIONS (2022)
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLPro)
Sang Hoon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf et al.
CELL REPORTS (2022)
Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
Chunlong Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)
Crystal structure of SARS-CoV-2 papain-like protease
Xiaopan Gao et al.
ACTA PHARMACEUTICA SINICA B (2021)
Can drug repurposing strategies be the solution to the COVID-19 crisis?
Carolina L. Bellera et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
C. Garrett Rappazzo et al.
SCIENCE (2021)
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
Maxwell T. Finkelstein et al.
VIRUSES-BASEL (2021)
Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
Robert M. Cox et al.
NATURE MICROBIOLOGY (2021)
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
Christoph Gorgulla et al.
ISCIENCE (2021)
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2
Wendy P. Painter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19
Steven S. Good et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Emma C. Thomson et al.
CELL (2021)
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
Ahmad Al-Abdouh et al.
CONTEMPORARY CLINICAL TRIALS (2021)
Waning Immunity after the BNT162b2 Vaccine in Israel
Yair Goldberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Yan Ling Ng et al.
PHARMACOLOGY & THERAPEUTICS (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Jerzy Osipiuk et al.
NATURE COMMUNICATIONS (2021)
Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
Ewelina Weglarz-Tomczak et al.
SCIENTIFIC REPORTS (2021)
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
Yining Wang et al.
VIROLOGY (2021)
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras et al.
NATURE COMMUNICATIONS (2021)
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
Chun-Hui Zhang et al.
ACS CENTRAL SCIENCE (2021)
Stabilized coronavirus spike stem elicits a broadly protective antibody
Ching-Lin Hsieh et al.
CELL REPORTS (2021)
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19
George R. Painter et al.
CURRENT OPINION IN VIROLOGY (2021)
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
Koen Vandyck et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography
Daniel W. Kneller et al.
IUCRJ (2021)
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
β-D-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Shuntai Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Structural basis for broad coronavirus neutralization
Maximilian M. Sauer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
Robert J. Geraghty et al.
VIRUSES-BASEL (2021)
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
Kyle Rosenke et al.
NATURE COMMUNICATIONS (2021)
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
Chunyan Wang et al.
NATURE COMMUNICATIONS (2021)
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
Thomas P. Peacock et al.
NATURE MICROBIOLOGY (2021)
Current Strategies of Antiviral Drug Discovery for COVID-19
Miao Mei et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation
Bahaa Jawad et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model
Rana Abdelnabi et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
A white-knuckle ride of open COVID drug discovery
Frank von Delft et al.
NATURE (2021)
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Prabhu S. Arunachalam et al.
NATURE (2021)
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
S. J. Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
Woo Dae Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants
Amarendra Pegu et al.
SCIENCE (2021)
Structure and function of SARS-CoV-2 polymerase
Hauke S. Hillen
CURRENT OPINION IN VIROLOGY (2021)
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
Chunlong Ma et al.
ACS CENTRAL SCIENCE (2021)
Incorporation efficiency and inhibition mechanism of 2′-substituted nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase
Congmin Yuan et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges
Adrian Gironda-Martinez et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
John S. Tregoning et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2
Hengyue Shan et al.
CELL CHEMICAL BIOLOGY (2021)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
Chunyan Yi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Forty years with coronaviruses
Susan R. Weiss
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
An open-source drug discovery platform enables ultra-large virtual screens
Christoph Gorgulla et al.
NATURE (2020)
Structure of replicating SARS-CoV-2 polymerase
Hauke S. Hillen et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr et al.
CELL (2020)
COVID-19: Drug Targets and Potential Treatments
Carmen Gil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes
Hua Guo et al.
JOURNAL OF VIROLOGY (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
Ramarao Poduri et al.
CELLULAR SIGNALLING (2020)
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Laura Riva et al.
NATURE (2020)
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Donghyuk Shin et al.
NATURE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
Egor P. Tchesnokov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Robert L. Hoffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Zunlong Ke et al.
NATURE (2020)
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
Dhan Bahadur Shrestha et al.
VIROLOGY JOURNAL (2020)
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
Ashleigh Shannon et al.
NATURE COMMUNICATIONS (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
Steffen Jockusch et al.
SCIENTIFIC REPORTS (2020)
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Lorenzo Casalino et al.
ACS CENTRAL SCIENCE (2020)
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design
Wioletta Rut et al.
SCIENCE ADVANCES (2020)
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
Jian Lei et al.
ANTIVIRAL RESEARCH (2018)
Future of nonnucleoside reverse transcriptase inhibitors
Nicolas Sluis-Cremer
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Mechanisms and Concepts in RNA Virus Population Dynamics and Evolution
Patrick T. Dolan et al.
ANNUAL REVIEW OF VIROLOGY, VOL 5 (2018)
The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner
Alex L. Lai et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease
Miklos Bekes et al.
MOLECULAR CELL (2016)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
In Vitro Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor
Warren Kati et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Travis K. Warren et al.
NATURE (2014)
One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities
Lorenzo Subissi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
Anna M. Mielech et al.
VIROLOGY (2014)
CORONAVIRUS GENOMICS AND BIOINFORMATICS ANALYSIS
Patrick C. Y. Woo et al.
OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
Jon Jacobs et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21
Yu Ye et al.
EMBO REPORTS (2011)
Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand X-ray Structure and Biological Evaluation
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Coronavirus Genomics and Bioinformatics Analysis
Patrick C. Y. Woo et al.
VIRUSES-BASEL (2010)
Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus
Santhana G. Devaraj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme
HA Lindner et al.
JOURNAL OF VIROLOGY (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity
BH Harcourt et al.
JOURNAL OF VIROLOGY (2004)
WebLogo: A sequence logo generator
GE Crooks et al.
GENOME RESEARCH (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
A major outbreak of severe acute respiratory syndrome in Hong Kong
N Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)